(Mark One)
|
|
|
x
|
ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
|
¨
|
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
|
Delaware
|
|
33-1127317
|
(State or other jurisdiction of
incorporation or organization) |
|
(I.R.S. Employer
Identification Number) |
Title of each class
|
|
Name of each exchange on which registered
|
Common Stock, par value $0.0001
|
|
The NASDAQ Stock Market LLC
|
(NASDAQ Global Select Market)
|
|
|
Page
|
|
|
|
Item 11.
|
Executive Compensation
|
8
|
Item 12.
|
Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters
|
19
|
Item 13.
|
Certain Relationships and Related Transactions and Director Independence
|
21
|
Item 14.
|
Principal Accounting Fees and Services
|
22
|
|
|
|
|
|
|
|
Age
|
|
Position
|
|
Director
Since |
|
Current
Term Expires |
Jack Lazar (1)(2)
|
|
53
|
|
Director
|
|
2016
|
|
2019
|
John Scull (3)
|
|
62
|
|
Director
|
|
2014
|
|
2019
|
Mark Stevens (2)(5)
|
|
59
|
|
Director
|
|
2016
|
|
2019
|
Sam Heidari
|
|
52
|
|
Chairman and Chief Executive Officer
|
|
2011
|
|
2020
|
Harold Hughes (4)(5)
|
|
73
|
|
Director
|
|
2014
|
|
2020
|
Glenda Dorchak (6)
|
|
64
|
|
Director
|
|
2018
|
|
2021
|
Edwin (Ned) B. Hooper III (7)
|
|
51
|
|
Director
|
|
2014
|
|
2021
|
(1)
|
Chairperson of our Nominating and Corporate Governance Committee.
|
(2)
|
Member of our Audit Committee.
|
(3)
|
Member of our Nominating and Corporative Governance Committee.
|
(4)
|
Chairperson of our Audit Committee.
|
(5)
|
Member of our Compensation Committee.
|
(6)
|
Chairperson of our Compensation Committee.
|
(7)
|
Lead Independent Director.
|
•
|
selecting a qualified firm to serve as the independent registered public accounting firm to audit our financial statements;
|
•
|
helping to ensure and evaluate the independence and performance of the independent registered public accounting firm;
|
•
|
discussing the scope and results of the audit with the independent registered public accounting firm, and reviewing, with management and the independent registered public accounting firm, our interim and year-end results of operations;
|
•
|
developing procedures for employees to submit concerns confidentially and anonymously about questionable accounting or audit matters;
|
•
|
reviewing our policies on risk assessment and risk management;
|
•
|
reviewing the adequacy and effectiveness of our internal controls;
|
•
|
reviewing related party transactions; and
|
•
|
approving or, as required, pre-approving, all audit and all permissible non-audit services, other than de minimis non-audit services, to be performed by the independent registered public accounting firm.
|
•
|
reviewing, approving and determining, or making recommendations to our Board of Directors regarding, the compensation of our executive officers;
|
•
|
administering our equity compensation plans;
|
•
|
reviewing, approving and making recommendations to our Board of Directors regarding incentive compensation and equity compensation plans; and
|
•
|
establishing and reviewing general policies relating to compensation and benefits of our employees.
|
•
|
identifying, evaluating and selecting, or making recommendations to our Board of Directors regarding, nominees for election to our Board of Directors and its committees;
|
•
|
evaluating the performance of our Board of Directors and of individual directors;
|
•
|
considering and making recommendations to our Board of Directors regarding the composition of our Board of Directors and its committees;
|
•
|
reviewing developments in corporate governance practices;
|
•
|
evaluating the adequacy of our corporate governance practices and reporting; and
|
•
|
developing and making recommendations to our Board of Directors regarding corporate governance guidelines and matters.
|
Name
|
|
Age
|
|
Position
|
Sam Heidari
|
|
52
|
|
Chairman and Chief Executive Officer
|
Sean Sobers
|
|
49
|
|
Chief Financial Officer
|
David Carroll
|
|
57
|
|
Senior Vice President, Worldwide Sales
|
•
|
The Company untimely filed a Form 4 on May 18, 2018 for each of Sam Heidari, Dave Carroll and Sean Sobers.
|
Name and Principal Position
|
Year
|
Salary ($)
|
Bonus ($)
|
Stock Awards ($)(1)
|
Option Awards ($)(1)
|
Non-Equity Incentive Plan Compensation ($)(2)
|
Nonqualified Deferred Compensation Earnings ($)
|
All Other Compensation ($)(3)
|
|
Total ($)
|
Sam Heidari,
Chairman and Chief Executive Officer |
2018
2017
|
450,000
330,000
|
—
|
1,175,400
1,523,766
|
1,236,600
1,573,524
|
484,014
101,875
|
—
|
5,500
43,477
|
|
3,351,514
3,572,642
|
Sean Sobers,
Chief Financial Officer |
2018
2017
|
310,000
250,000
|
—
|
391,800
448,036
|
412,200
462,666
|
204,738
53,125
|
—
|
3,466
12,516
|
|
1,322,204
1,226,343
|
David Carroll,
Senior Vice President, Worldwide Sales |
2018
2017
|
278,000
230,000
|
—
|
339,560
412,548
|
357,240
426,020
|
222,653
84,375
|
—
|
3,270
29,254
|
|
1,200,723
1,182,197
|
(1)
|
The amounts disclosed represent the grant date fair value of the restricted stock units under “Stock Awards” and stock options under “Option Awards” granted to the named executive officers during fiscal 2017 and 2018 as computed in accordance with FASB ASC Topic 718. The assumptions used in calculating the grant date fair value of the stock options reported in this column are set forth in the notes to our consolidated financial statements included in our Annual Report on Form 10-K for the year ended December 31, 2017 and December 30, 2018, respectively.
|
(2)
|
The amounts included in this column represent cash incentives earned under our 2017 and 2018 bonus programs, respectively. See “Non-Equity Incentive Plan Compensation” section below for more details.
|
(3)
|
Consists of (i) for 2017 and 2018, a Company match of individual contributions to our 401(k) savings plan, subject to certain limitations and applicable vesting requirements, which is offered to all eligible Company employees for 2017, and (ii) for 2017, amounts for accrued paid time off (PTO) paid to employees in connection with a one-time change in the Company's PTO policy.
|
•
|
A lump sum severance payment equal to twelve months of his then-current base salary;
|
•
|
The ability to exercise each of his then-outstanding and vested stock options until the earlier of (x) three years from his termination date, (y) the original term / expiration date of each option, or (z) the date required by the terms of the equity plan under which such stock option was granted; and
|
•
|
If the termination is without cause in connection with Dr. Heidari’s removal by us from the Chief Executive Officer position or is a resignation for good reason, 25% of the then-unvested shares subject to Dr. Heidari’s outstanding equity awards will become fully vested.
|
•
|
A lump sum severance payment equal to four months of his then-current base salary (prior to any reduction of base salary constituting good reason);
|
•
|
A lump sum severance payment equal to one-third (1/3) of his then-current annual bonus;
|
•
|
If the termination occurs within the first twelve months of Mr. Sobers’ start date, the option granted to him on July 27, 2016 (the “July 2016 Option”) will no longer be subject to the one-year “cliff” vesting requirement described in the “Outstanding Equity Awards at Fiscal Year-End” table below, and instead will be deemed to have vested as to 1/48th of the shares subject to the July 2016 Option for each month from his employment start date; and
|
•
|
Acceleration of vesting of each of Mr. Sobers’ then-outstanding stock options other than the July 2016 Option as to the number of shares subject to each such option that would have otherwise vested in the four months after his termination of employment.
|
•
|
a lump sum severance payment equal to 12 months of his then-current base salary;
|
•
|
a lump sum severance payment equal to 100% of his target bonus for the year of termination;
|
•
|
Company-reimbursed premiums for continued health care coverage under COBRA for up to 12 months for the executive officer and his eligible dependents or, if the Company determines that it cannot provide the COBRA premium benefits without potentially violating applicable laws, a lump sum payment equal to 12 months of COBRA premiums for the executive officer and his eligible dependents; and
|
•
|
100% of shares subject to all outstanding equity awards with time-based vesting will become fully vested, and, for any outstanding equity awards with performance-based vesting, the performance metrics will be deemed achieved at target levels.
|
|
|
|
Option Awards
|
Stock Awards
|
|||||||||||||||||||
Name
|
|
Grant Date
|
|
|
Number of
Securities Underlying Unexercised Options Exercisable (#)
|
|
Number of
Securities Underlying Unexercised Options Unexercisable(#)
|
|
Option Exercise Price ($)
|
|
Option Expiration Date
|
|
Number of Shares of Stock That Have Not Vested
|
|
Market Value of Shares of Stock That Have Not Vested ($)(1)
|
||||||||
Sam
Heidari |
|
07/28/2009
|
|
|
—
|
|
—
|
|
2.50
|
|
07/28/2019
|
|
—
|
|
—
|
||||||||
|
|
05/18/2010
|
|
|
—
|
|
—
|
|
1.00
|
|
05/18/2020
|
|
—
|
|
—
|
||||||||
|
|
02/01/2011
|
|
|
25,200
|
|
—
|
|
1.00
|
|
02/01/2021
|
|
—
|
|
—
|
||||||||
|
|
10/07/2011
|
|
|
74,991
|
|
—
|
|
1.00
|
|
10/07/2021
|
|
—
|
|
—
|
||||||||
|
|
06/27/2012
|
|
|
416,985
|
|
—
|
|
1.50
|
|
06/27/2022
|
|
—
|
|
—
|
||||||||
|
|
08/28/2013
|
|
|
130,000
|
|
—
|
|
1.50
|
|
08/28/2023
|
|
—
|
|
—
|
||||||||
|
|
12/10/2014
|
(2)
|
|
414,623
|
|
—
|
|
2.00
|
|
12/10/2024
|
|
—
|
|
—
|
||||||||
|
|
06/30/2016
|
(3)
|
|
112,501
|
|
67,499
|
|
8.50
|
|
06/30/2026
|
|
—
|
|
—
|
||||||||
|
|
02/15/2017
|
(4)
|
|
78,718
|
|
93,032
|
|
22.18
|
|
02/15/2027
|
|
—
|
|
—
|
||||||||
|
|
02/15/2017
|
(5)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
42,937
|
|
607,129
|
||||||||
|
|
1/10/2018
|
(11)
|
|
—
|
|
225,000
|
|
13.06
|
|
1/10/2028
|
|
|
|
|
||||||||
|
|
1/10/2018
|
(12)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
78,750
|
|
1,113,525
|
||||||||
Sean
Sobers |
|
07/27/2016
|
(6)
|
|
168,043
|
|
117,905
|
|
9.00
|
|
07/27/2026
|
|
—
|
|
—
|
||||||||
|
|
02/15/2017
|
(4)
|
|
23,145
|
|
27,355
|
|
22.18
|
|
02/15/2027
|
|
—
|
|
—
|
||||||||
|
|
02/15/2017
|
(5)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
12,625
|
|
178,517
|
||||||||
|
|
1/10/2018
|
(11)
|
|
—
|
|
75,000
|
|
13.60
|
11
|
1/10/2028
|
|
—
|
|
—
|
||||||||
|
|
1/10/2018
|
(12)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
26,250
|
|
371,175
|
||||||||
David
Carroll |
|
02/05/2013
|
(7)
|
|
20,929
|
|
—
|
|
1.50
|
|
02/05/2023
|
|
—
|
|
—
|
||||||||
|
|
12/10/2014
|
(8)
|
|
125
|
|
—
|
|
2.00
|
|
12/10/2024
|
|
—
|
|
—
|
||||||||
|
|
12/03/2015
|
(9)
|
|
272
|
|
1,872
|
|
3.00
|
|
12/03/2025
|
|
—
|
|
—
|
||||||||
|
|
06/30/2016
|
(3)
|
|
18,967
|
|
13,871
|
|
8.50
|
|
06/30/2026
|
|
—
|
|
—
|
||||||||
|
|
02/15/2017
|
(4)
|
|
21,312
|
|
25,188
|
|
22.18
|
|
02/15/2027
|
|
—
|
|
—
|
||||||||
|
|
02/15/2017
|
(5)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
11,625
|
|
164,377
|
||||||||
|
|
1/10/2018
|
(11)
|
|
—
|
|
65,000
|
|
13.06
|
|
1/10/2028
|
|
—
|
|
—
|
||||||||
|
|
1/10/2018
|
(12)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
22,750
|
|
326,463
|
(1)
|
This column represents the market value of the shares underlying the restricted stock units, or RSUs, as of December 30, 2018, based on the closing price of our common stock, as reported on the NASDAQ Stock Market, of $14.14 per share on December 28, 2018.
|
(2)
|
One-fourth (1/4) of the shares subject to the option vested on December 10, 2015, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service to us on each such vesting date.
|
(3)
|
One-fourth (1/4) of the shares subject to the option vested on June 30, 2017, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service to us on each such vesting date.
|
(4)
|
One-fourth(1/4) of the shares subject to the option will vest on February 20, 2018, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service on each such vesting date.
|
(5)
|
One-eighth (1/8) of the shares subject to the restricted stock units vested on August 20, 2017 and each six-month anniversary thereafter, subject to continued service on each such vesting date.
|
(6)
|
One fourth (1/4) of the shares subject to the option vested on July 25, 2017, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service to us on each such vesting date.
|
(7)
|
One fourth (1/4) of the shares subject to the option vested on January 7, 2014, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service to us on each such vesting date.
|
(8)
|
One fourth (1/4) of the shares subject to the option vested on December 10, 2015, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service to us on each such vesting date.
|
(9)
|
One fourth (1/4) of the shares subject to the option shall vest on December 3, 2016, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service to us on each such vesting date.
|
(10)
|
One fourth (1/4) of the shares subject to the option vested on June 30, 2017, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service on each such vesting date.
|
(11)
|
One fourth (1/4) of the shares subject to the option shall on January 10, 2019, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service on each such vesting date.
|
(12)
|
One eighth (1/8) of the shares subject to the award vested on August 20, 2018, and one eighth (1/8) of the shares vest quarterly thereafter, subject to continued service on each such vesting date.
|
•
|
$35,000 per year for service as a board member;
|
•
|
$20,000 per year additionally for service as lead independent director of the board;
|
•
|
$15,000 ($20,000, effective as of April 1, 2019) per year additionally for service as chair of the Audit Committee;
|
•
|
$7,500 ($10,000 effective as of April 1, 2019) per year additionally for service as an Audit Committee member other than chair;
|
•
|
$10,000 ($11,000 effective as of April 1, 2019) per year additionally for service as chair of the Compensation Committee;
|
•
|
$5,000 ($6,000 effective as of April 1, 2019) per year additionally for service as a Compensation Committee member other than chair;
|
•
|
$5,000 ($8,000 effective as of April 1, 2019) per year additionally for service as chair of the Nominating and Corporate Governance Committee; and
|
•
|
$2,500 ($5,000 effective as of April 1, 2019) per year additional for services as a Nominating and Corporate Governance Committee member other than chair.
|
|
|
|
|
|
|
|
Director
|
|
Fees Earned or Paid in Cash ($)
|
|
Stock
Awards($) (1) |
|
Total
Compensation
|
Glenda Dorchak (2)
|
|
24,665
|
|
269,986
|
|
294,651
|
Edward Frank (3)
|
|
27,161
|
|
134,985
|
|
162,146
|
Edwin (Ned) B. Hooper III
|
|
56,541
|
|
134,985
|
|
191,526
|
Harold Hughes
|
|
51,808
|
|
134,985
|
|
186,793
|
Jack Lazar
|
|
46,727
|
|
134,985
|
|
181,712
|
John Scull
|
|
37,500
|
|
134,985
|
|
172,485
|
Mark Stevens
|
|
47,500
|
|
134,985
|
|
182,485
|
Lip-Bu Tan (4)
|
|
17,556
|
|
-
|
|
17,556
|
(1)
|
The amounts reported represent the aggregate grant-date fair value of the restricted stock units awarded to the non-employee directors, calculated in accordance with the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”) Topic 718. The assumptions used in calculating the grant-date fair value of the restricted stock units reported in this column are set forth in Note 10 to our audited consolidated financial statements included in our Annual Report on Form 10-K, as filed with the SEC on March 1, 2019.
|
(2)
|
Ms. Dorchak joined the Board of Directors on June 5, 2018.
|
(3)
|
The stock awards granted to Mr. Frank in our fiscal year ended December 30, 2018 reflected in the above table (and prior unvested equity awards) were automatically cancelled in connection with his resignation.
|
(4)
|
Mr. Tan resigned from the Board of Directors on June 5, 2018.
|
|
|
Option Awards
|
|
Stock Awards
|
|||||||||||||||
Name
|
|
Grant Date
|
|
|
Number of
Securities Underlying Unexercised Options (#) Exercisable
|
|
Number of
Securities Underlying Unexercised Options (#) Unexercisable
|
|
Option Exercise Price ($)(1)
|
|
Option Expiration Date
|
|
Number of
Shares of Stock that Have Not Vested |
|
Market Value of Shares of Stock that Have Not Vested ($) (2)
|
||||
Glenda Dorchak
|
|
6/5/2018
|
(3)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
16,635
|
|
235,219
|
||||
Edwin (Ned) B. Hooper III
|
|
6/5/2018
|
(4)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
8,317
|
|
117,602
|
||||
Harold Hughes
|
|
10/16/2014
|
(5)
|
|
64,000
|
|
—
|
|
$2.00
|
|
10/16/2024
|
|
—
|
|
—
|
||||
|
|
6/30/2016
|
(6)
|
|
8,000
|
|
—
|
|
$8.50
|
|
6/30/2026
|
|
—
|
|
—
|
||||
|
|
6/5/2018
|
(4)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
8,317
|
|
117,602
|
||||
Jack Lazar
|
|
7/13/2016
|
(7)
|
|
72,000
|
|
—
|
|
$8.50
|
|
7/13/2026
|
|
|
|
|
||||
|
|
6/5/2018
|
(4)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
8,317
|
|
117,602
|
||||
|
|
6/5/2018
|
(4)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
8,317
|
|
117,602
|
||||
Mark Stevens
|
|
7/13/2016
|
(7)
|
|
72,000
|
|
—
|
|
$8.50
|
|
7/13/2026
|
|
|
|
|
||||
|
|
6/5/2018
|
(4)
|
|
—
|
|
—
|
|
—
|
|
—
|
|
8,317
|
|
117,602
|
(1)
|
The column represents the fair market value of our common stock on the date of grant as determined by our Board of Directors.
|
(2)
|
This column represents the market value of the shares underlying the RSUs or restricted stock as of December 30, 2018, based on the closing price of our common stock, as reported on the NASDAQ Stock Market, of $14.14 per share on December 28, 2018.
|
(3)
|
One-third of the RSUs will vest on the one-year anniversary of the date of grant, or if earlier, on the day prior to the Company's next annual meeting of stockholders occurring after the grant date, subject to continued service as of the applicable vesting date. An additional one-third (1/3rd) of the shares shall vest on the two-year anniversary of the date of grant, or, if earlier, on the day prior to the second (2nd) Annual Meeting following the date of grant. The final one-third (1/3rd) of the shares shall vest on the three-year anniversary of the date of grant, or if earlier, on the day prior to the third (3rd) Annual Meeting.
|
(4)
|
100% of the RSUs will vest upon the earlier of the one (1) year anniversary of the grant date or the day prior to the Company's next annual meeting of stockholders occurring after the grant date, in each case, subject to continued service as of the applicable vesting date.
|
(5)
|
One forty-eighth (1/48) of the shares subject to the option vested on October 16, 2014, and one forty-eighth (1/48) of the shares vest monthly thereafter, subject to continued service on each such vesting date.
|
(6)
|
This option is subject to an early exercise provision and is immediately exercisable. One thirty-sixth (1/36) of the shares subject to the option vest monthly commencing on June 30, 2016, and one thirty-sixth (1/36) of the shares vest monthly thereafter, subject to continued service on each such vesting date.
|
(7)
|
This option is subject to an early exercise provision and is immediately exercisable. One thirty-sixth (1/36) of the shares subject to the option vest monthly commencing on July 6, 2016, and one thirty-sixth (1/36) of the shares vest monthly thereafter, subject to continued service on each such vesting date.
|
Plan Category
|
|
(a) Number of Securities to be Issued Upon Exercise of Outstanding Options, Warrants and Rights
|
|
(b) Weighted Average Exercise Price of Outstanding Options, Warrants and Rights
(1)
|
|
(c) Number of Securities Remaining Available for Future Issuance Under Equity Compensation Plans (Excluding Securities Reflected in Column (a))
|
|
Equity compensation plans approved by stockholders(1)
|
|
6,280,583
|
|
$
|
8.27
|
|
2,543,188
|
Equity compensation plans not approved by stockholders
|
|
—
|
|
—
|
|
—
|
|
Total
|
|
6,280,583
|
|
$
|
8.27
|
|
2,543,188
|
(1)
|
Includes our 2006 Stock Plan, 2016 Equity Incentive Plan and the 2016 Omnibus Equity Incentive Plan. The 2016 Omnibus Equity Incentive Plan contains an “evergreen” provision, pursuant to which the number of shares of common stock reserved for issuance pursuant to awards under such plan shall be increased on the first day of each year beginning in 2018, equal to the least of (i) 3,400,000 shares, (ii) 5.0% of the shares of common stock outstanding on the last day of the immediately preceding fiscal year, or (iii) such number as determined by the plan administrator. As of January 1, 2018, the 2016 Omnibus Equity Incentive Plan was increased by 1,776,444 shares pursuant to such evergreen provision.
|
|
Shares Beneficially Owned
|
||
Name of Beneficial Owner
|
Number
|
Percent
|
|
Named Executive Officers and Directors
|
|
|
|
Sam Heidari
(1)
|
1,380,844
|
|
3.47%
|
Sean Sobers
(2)
|
283,018
|
|
*
|
David Carroll
(3)
|
53,612
|
|
*
|
Glenda Dorchak
|
—
|
|
*
|
Edwin (Ned) B. Hooper III
(4)
|
56,693
|
|
*
|
Harold Hughes
(5)
|
79,127
|
|
*
|
Jack Lazar
(6)
|
93,616
|
|
*
|
John Scull
(7)
|
1,734,561
|
|
4.51%
|
Mark Stevens
(8)
|
145,908
|
|
*
|
All executive officers and directors as a group (9 persons)
(9)
|
3827,379
|
|
9.51%
|
5% Stockholders
|
|
|
|
BlackRock, Inc.
(10)
|
2,252,719
|
|
5.86%
|
JPMorgan Chase & Co.
(11)
|
2,089,649
|
|
5.43%
|
Entities affiliated with DAG Ventures
(12)
|
1,970,342
|
|
5.12%
|
*
|
Represents beneficial ownership of less than one percent (1%) of the outstanding shares of our common stock.
|
(1)
|
Consists of (i) 103,176 shares held of record by Dr. Heidari and (ii) 1,277,668 shares subject to equity awards exercisable or releasable within 60 days of March 31, 2019.
|
(2)
|
Consists of (i) 30,540 share held of record by Mr. Sobers and (ii) 252,478 shares subject to equity awards exercisable or releasable within 60 days of March 31, 2019.
|
(3)
|
Consists of (i) 17,560 shares held of record by Mr. Carroll and (ii) 36,052 shares subject to equity awards exercisable or releasable within 60 days of March 31, 2019.
|
(4)
|
Consists of (i) 23,100 shares held of record by Mr. Hooper and (ii) 33,593 shares held by Centerview Capital Technology Employee Fund, L.P., (“Centerview”). Mr. Hooper is a managing partner of Centerview and shares voting and investment power with respect to the shares held by Centerview. The address for Centerview is 64 Willow Place, Suite 101, Menlo Park, California 94025.
|
(5)
|
Consists of (i) 7,127 shares held of record by Mr. Hughes and (ii) 72,000 shares subject to equity awards exercisable or releasable within 60 days of March 31, 2019, of which 222 shares are unvested and subject to a right of repurchase by us, if Mr. Lazar does not satisfy such option’s vesting requirements.
|
(6)
|
Consists of (i) 21,616 shares held of record Mr. Lazar and (ii) 72,000 shares subject to equity awards exercisable or releasable within 60 days of March 31, 2019, of which 4,000 shares are unvested and subject to a right of repurchase by us, if Mr. Lazar does not satisfy such option’s vesting requirements.
|
(7)
|
Consists of (i) 7,127 shares held of record by Mr. Scull and (ii) 1,727,434 shares held by Southern Cross Venture Partners Management Pty Ltd as trustee for Southern Cross Fund No 1 Trust (“Southern Cross”). Mr. Scull is a director of Southern Cross Venture Partners Pty Ltd and shares voting and investment power with respect to the shares held by Southern Cross Venture Partners Management Pty Ltd as trustee for Southern Cross Fund No 1 Trust. The address for Southern Cross is 80 Mount Street, Level 7, North Sydney, NSW, Australia, 2060.
|
(8)
|
Consists of (i) 58,908 shares held of record by Mr. Stevens, (ii) 15,000 shares purchased in our directed share program at the closing of our initial public offering by S-Cubed Capital (“SCC”), of which Mr. Stevens is the managing partner and has voting and investment power with respect to the shares held by SCC and (iii) 72,000 shares subject to equity awards exercisable or releasable within 60 days of March 31, 2019, of which 4,000 shares are unvested and may be acquired upon early exercise, subject to a right of repurchase by us, if Mr. Stevens does not satisfy such option’s vesting requirements.
|
(9)
|
Consists of (i) 2,045,181 shares held by our current directors and executive officers and (ii) 1,782,198 shares subject to equity awards held by our current directors and executive officers and exercisable or releasable within 60 days of March 31, 2019.
|
(10)
|
According to a Schedule 13G filed with the SEC on February 8, 2019, the shares consist of 2,252,719 shares held by BlackRock, Inc. (“BlackRock”). Of the shares of our common stock that BlackRock beneficially owned, BlackRock reported that it has sole voting power with respect to 2,185,854 shares of our common stock and sole dispositive power with respect to 2,252,719 shares of our common stock. The address of BlackRock is 55 East 52nd Street, New York, New York 10055.
|
(11)
|
According to a Schedule 13G filed with the SEC on January 14, 2019, the shares consist of 2,089,649 shares held by JPMorgan Chase & Co and its wholly-owned subsidiaries, J.P. Morgan Investment Management Inc. and JPMorgan Chase Bank, National Association (together, “JPMorgan”). Of the shares of our common stock that JPMorgan beneficially owned, JPMorgan reported that it has sole voting power with respect to 1,884,255 shares of our common stock and sole dispositive power with respect to 2,089,649 shares of our common stock. The address of JPMorgan is 270 Park mer Avenue, New York, New York 10017.
|
(12)
|
According to a Schedule13G/A filed with the SEC on February 12, 2018, the shares consist of (i) 1,633,818 shares held by DAG Ventures IV-QP, L.P. (“DAG IV-QP”) (ii) 163,862 shares held by DAG Ventures IV-A, LLC (“DAG IV-A”) and (iii) 172,662 shares held by DAG Ventures IV, L.P. (“DAG IV”). DAG Ventures Management IV, LLC (“DAG IV LLC”) serves as the general partner of DAG IV-QP and DAG IV, and serves as the manager of DAG IV-A. As such, DAG IV LLC possesses power to direct the voting and disposition of the shares owned by DAG IV-QP, DAG IV and DAG IV-A and may be deemed to have indirect beneficial ownership of the shares held by DAG IV-QP, DAG IV and DAG IV-A. DAG IV LLC owns no shares directly. Messrs. R. Thomas Goodrich and John J. Cadeddu are Managing Directors of DAG IV LLC. As such, Messrs. R. Thomas Goodrich and John J. Cadeddu possess power to direct the voting and disposition of the shares owned by DAG IV-QP, DAG IV and DAG IV-A and may be deemed to have indirect beneficial ownership of the shares held by DAG IV-QP, DAG IV and DAG IV-A. Messrs. R. Thomas Goodrich and John J. Cadeddu own no shares directly. The address each of the entities identified in this footnote is 251 Lytton Avenue, Suite 200, Palo Alto, California 94301.
|
•
|
we have been or are to be a participant;
|
•
|
the amount involved exceeded or will exceed $120,000; and
|
•
|
any of our directors, executive officers or holders of more than 5% of our outstanding capital stock, or any immediate family member of, or person sharing the household with, any of these individuals or entities, had or will have a direct or indirect material interest.
|
|
2018
|
|
2017
|
|||||
Audit Fees (1)
|
$
|
1,324,500
|
|
|
$
|
1,313,300
|
|
|
Audit-Related Fees
|
$
|
—
|
|
|
$
|
—
|
|
|
Tax Fees (2)
|
$
|
360,509
|
|
|
$
|
423,261
|
|
|
All Other Fees (3)
|
$
|
900
|
|
|
$
|
2,250
|
|
|
Total Fees
|
$
|
1,685,909
|
|
|
$
|
1,738,811
|
|
|
(1)
|
Audit Fees consist of professional services provided in connection with the audit of our annual consolidated financial statements, the review of our unaudited quarterly consolidated financial statements, and audit services that are normally provided by the independent registered public accounting firm in connection with statutory and regulatory filings or engagements for those fiscal years.
|
(2)
|
Tax Fees consist of fees for professional services for tax compliance, tax advice, tax planning, and employee benefit plan tax services. These services include assistance regarding federal, state and international tax compliance.
|
(3)
|
All Other Fees consist of fees for access to PwC's online accounting research tool and Global Best Practices database.
|
•
|
reviewed and discussed the audited financial statements with management and PwC;
|
•
|
discussed with PwC the matters required to be discussed by the statement on Auditing Standards No. 1301,
Communications with Audit Committees
; and
|
•
|
received the written disclosures and the letter from PwC required by applicable requirements of the Public Company Accounting Oversight Board regarding the independent accountant’s communications with the Audit Committee concerning independence, and has discussed with PwC its independence.
|
|
|
Incorporated by Reference
|
|
||||
Exhibit
Number |
Description
|
Form
|
File No.
|
Exhibit
|
Filing Date
|
||
S-1
|
333-213871
|
3.2
|
September 29, 2016
|
||||
8-K
|
001-37927
|
3.1
|
August 22, 2017
|
||||
S-1/A
|
333-213871
|
4.1
|
October 17, 2016
|
||||
10.1
+
|
S-1
|
333-213871
|
10.1
|
September 29, 2016
|
|||
10.2
+
|
10-K
|
001-37927
|
10.2
|
March 1, 2017
|
|||
10.3
+
|
10-K
|
001-37927
|
10.3
|
March 1, 2017
|
|||
10.4
+
|
S-1/A
|
333-213871
|
10.4
|
October 17, 2016
|
|||
10.5
+
|
S-1/A
|
333-213871
|
10.5
|
October 17, 2016
|
|||
10.6
+
|
S-1
|
333-213871
|
10.6
|
September 29, 2016
|
|||
S-1
|
333-213871
|
10.16
|
September 29, 2016
|
||||
S-1/A
|
333-213871
|
10.17
|
October 17, 2016
|
||||
10.9
+
|
S-1/A
|
333-213871
|
10.18
|
October 27, 2016
|
|||
10.10
+
|
S-1
|
333-213871
|
10.23
|
September 29, 2016
|
10.11
+
|
S-1
|
333-213871
|
10.26
|
September 29, 2016
|
|||
10.12
+
|
S-1
|
333-213871
|
10.28
|
September 29, 2016
|
|||
10.13
+
|
S-1
|
333-213871
|
10.30
|
September 29, 2016
|
|||
10.14
+
|
S-1
|
333-213871
|
10.31
|
September 29, 2016
|
|||
10.15
+
|
S-1/A
|
333-213871
|
10.32
|
October 17, 2016
|
|||
10.16
+
|
10-K
|
001-37927
|
10.33
|
March 1, 2017
|
|||
10.17
+
|
10-K
|
001-37927
|
10.34
|
March 1, 2017
|
|||
10-K
|
001-37927
|
10.35
|
March 1, 2017
|
||||
10.19
+
|
10-Q
|
001-37927
|
10.36
|
May 1, 2018
|
|||
10.20
+
|
10-Q
|
001-37927
|
10.37
|
May 1, 2018
|
|||
21.1
*
|
|
|
|
|
|||
23.1
*
|
|
|
|
|
|||
31.1
**
|
|
|
|
|
|||
31.2
**
|
|
|
|
|
|||
32.1
*
|
|
|
|
|
|||
101.INS*
|
XBRL Instance Document.
|
|
|
|
|
||
101.SCH*
|
XBRL Taxonomy Extension Schema Document.
|
|
|
|
|
||
101.CAL*
|
XBRL Taxonomy Extension Calculation Linkbase Document.
|
|
|
|
|
||
101.DEF*
|
XBRL Taxonomy Extension Definition Linkbase Document.
|
|
|
|
|
||
101.LAB*
|
XBRL Taxonomy Extension Label Linkbase Document.
|
|
|
|
|
||
101.PRE*
|
XBRL Taxonomy Extension Presentation Linkbase Document.
|
|
|
|
|
+
|
Indicates management contract or compensatory plan.
|
*
|
Filed or furnished with the original Form 10-K filed with the Securities and Exchange Commission on March 1, 2019.
|
**
|
Filed herewith.
|
|
QUANTENNA COMMUNICATIONS, INC.
|
|
|
|
|
|
By:
|
/s/ Sam Heidari
|
|
|
Sam Heidari
|
|
|
Chairman and Chief Executive Officer
|
|
|
|
|
By:
|
/s/ Sean Sobers
|
|
|
Sean Sobers
|
|
|
Chief Financial Officer
|
|
|
|
Date:
|
April 26, 2019
|
|
By:
|
/s/ Sam Heidari
|
||
|
|
|
Name:
|
Sam Heidari
|
||
|
|
|
Title:
|
Chief Executive Officer (Principal Executive Officer)
|
Date:
|
April 26, 2019
|
|
By:
|
/s/ Sean Sobers
|
||
|
|
|
Name:
|
Sean Sobers
|
||
|
|
|
Title:
|
Chief Financial Officer (Principal Financial Officer)
|